CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- 4 Planned sale Chief Legal Officer sold 10,250 shares at $40.52 ($415,330)
- 4 Planned sale Director sold 108,073 shares at an average $44.55 ($4,814,205)
- 4 Planned sale Director sold 108,073 shares at an average $44.55 ($4,814,205)
- 4 Open-market sale Director sold 30,316 shares at an average $39.61 ($1,200,704)
- 4 Open-market sale Director sold 136,351 shares at an average $40.34 ($5,500,158)
- 4 Open-market sale Director sold 373,610 shares at an average $39.51 ($14,762,604)
- 4 Planned sale President & CEO sold 99,800 shares at an average $36.26 ($3,618,560)
- 4 Planned sale Director sold 88,878 shares at an average $34.22 ($3,041,683)
- 4 Planned sale Director sold 286,369 shares at an average $32.30 ($9,251,102)
- 4 Planned sale President & CEO sold 25,200 shares at an average $31.28 ($788,153)
- 4 Planned sale Director sold 194,932 shares at an average $30.47 ($5,939,784)
- 4 Planned sale Director sold 49,546 shares at an average $29.99 ($1,485,790)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 78,693 shares at an average $30.08 ($2,367,473)
- 4 Planned sale President & CEO sold 25,000 shares at an average $29.11 ($727,798)
- 4 Planned sale Chief Legal Officer sold 10,250 shares at $23.12 ($236,980)
- 4 Planned sale CFO & Head of Corp. Dev. sold 9,584 shares at an average $25.09 ($240,442)
- 4 Planned sale President & CEO sold 25,000 shares at an average $24.97 ($624,361)
- 4 Planned sale CFO & Head of Corp. Dev. sold 23,416 shares at an average $25.70 ($601,858)
Page 3 of 5 · 100 filings